Chronic inflammatory demyelinating polyneuropathy: Difference between revisions

Line 5: Line 5:


==Clinical Features==
==Clinical Features==
 
*Symmetrical proximal and distal muscle weakness that is progressive for more than two months
*Impaired sensation
*Areflexia
*Elevated CSF protein
*EMG studies consistent with demyelination
*Nerve demyelination on nerve biopsies
Can be relapsing or chronic and progressive


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 17:41, 12 September 2020

Background

  • Prevalence of 1 to 2 per 100,000 adults
  • Acute variant is Guillain-Barre syndrome
    • GBS is self limited whereas CIPD is progressive for more than two months

Clinical Features

  • Symmetrical proximal and distal muscle weakness that is progressive for more than two months
  • Impaired sensation
  • Areflexia
  • Elevated CSF protein
  • EMG studies consistent with demyelination
  • Nerve demyelination on nerve biopsies

Can be relapsing or chronic and progressive

Differential Diagnosis

Weakness

Evaluation

Workup

Diagnosis

Management

Disposition

See Also

External Links

References